Maia M

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.Chaccour C, Casellas A, Hammann F, Ruiz-Castillo P, Nicolas P, Montaña J, Mael M, Selvaraj P, Duthaler U, Mrema S, Kakolwa M, Lyimo I, Okumu F, Marathe A, Schürch R, Elobolobo E, Sacoor C, Saute F, Xia K, Jones C, Rist C, Maia M, Rabinovich NR
Trials, (2023). 24:128

Vectorial capacity and TEP1 genotypes of Anopheles gambiae sensu lato mosquitoes on the Kenyan coast.Bartilol B, Omuoyo D, Karisa J, Ominde K, Mbogo C, Mwangangi J, Maia M, Rono MK
Parasit Vectors, (2022). 15:448

Malaria vector bionomics in Taita-Taveta County, coastal Kenya.Karisa J, Ominde K, Muriu S, Munyao V, Mwikali K, Babu L, Ondieki Z, Bartilol B, Tuwei M, Wanjiku C, Maia M, Midega J, Rono M, Peshu N, Mbogo C, Mwangangi JM
Parasit Vectors, (2022). 15:430

Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study.Nicolas P, Kiuru C, Wagah MG, Muturi M, Duthaler U, Hammann F, Maia M, Chaccour C
Parasit Vectors, (2021). 14:172

Effectiveness of Rotarix ((R)) vaccine in Africa in the first decade of progressive introduction, 2009-2019: systematic review and meta-analysis.Murunga N, Otieno PG, Maia M, Agoti CN
Wellcome Open Res, (2020). 5:187

Can trials of spatial repellents be used to estimate mosquito movement?.Malinga J, Maia M, Moore S, Ross A
Parasit Vectors, (2019). 12:421

Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.Chaccour CJ, Hammann F, Alustiza M, Castejon S, Tarimo BB, Abizanda G, Irigoyen Barrio A, Marti Soler H, Moncada R, Bilbao JI, Aldaz A, Maia M, Del Pozo JL
Sci Rep, (2017). 7:8535